Le Loarer et al. [1] found that SMARCA4-UT was often accompanied by the loss of SMARCA2, whereas SMARCA4-deficient NSCLC was usually not accompanied by the loss of SMARCA2, and CD34 was less expressed in SMARCA4-deficient NSCLC [47]. The gene discussed is CD34; the disease is non-small cell lung carcinoma.